Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence

Alcohol

Volumn 20, Issue 3, 2000, Pages 257-262

  Gallimberti, Luigi ^a   Spella, Maurizio Raffaele ^b   Soncini, Carlo Alberto ^b   Gessa, Gian Luigi ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b Addictive Behavior Medical Center   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Alcohol craving and consumption; Alcohol withdrawal syndrome; Alcoholics; Gamma hydroxybutyric acid; Heroin addicted; Opiate withdrawal syndrome

Indexed keywords

4 HYDROXYBUTYRIC ACID; ALCOHOL; DIAMORPHINE; METHADONE; NALOXONE; NALTREXONE;

ABSTINENCE; AGITATION; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ASTHENIA; CLINICAL TRIAL; CONFERENCE PAPER; CONFUSION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG INDUCED DISEASE; HALLUCINATION; HEROIN DEPENDENCE; HUMAN; NAUSEA; RESPIRATORY FAILURE; VERTIGO; WITHDRAWAL SYNDROME;

ALCOHOLISM; CLINICAL TRIALS; HEROIN DEPENDENCE; HUMANS; HYDROXYBUTYRATES; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

TRIXIS;

EID: 0034086933     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-8329(99)00089-0     Document Type: Conference Paper

References (47)

1. Addolorato G., Caputo F., Capristo E., Stefanini G.F., Gasbarrini G. Gamma-hydroxybutyric acid. efficacy, potential abuse, and dependence in the treatment of alcohol addiction Alcohol. 20:2000;217-222.
2. Practice guidelines for the treatment of patients with substance use disorders. alcohol, cocaine, opioids Am J Psychiatry. 152(suppl.):1995.
3. Appia O. Apport d'un matériel onirique à la psychothérapie par l'utilisation du 4 hydroxybutyrate de sodium. Agressologie. 8:1967;577-582.
4. Benda, P., Deshaies, G., Perlès, R., Deshaies-Pellier, M. S., & Rosenberger-Debiesse, J. (1960). Premier essai de la butyrolactone en clinique. Societé Medico-Psychologique (Saint Maurice, Seine), pp. 770-775.
5. Broughton R., Mamelak M. The treatment of narcolepsy-cataplexy with nocturnal gamma-hydroxybutyrate. J Can Sci Neurol. 6:1979;1-6.
6. Multistate outbreak of poisonings associated with illicit use of gamma hydroxybutyrate. J Am Med Assoc. 265:1991;447-448.
7. Chin M.Y., Kreutzer R.A., Dyer J.E. Acute poisoning from gamma-hydroxybutyrate in California. West J Med. 156:1992;380-384.
8. De Couedic H., Voisse M. Contribution à l'étude du 4-hydroxybutyrate de Na (4-OH) dans le traitement des états anxieux aigus. Rev Agressol. 5:1964;73-84.
9. Dyer J.E. Gamma-hydroxybutyrate. a health-food product producing coma and seizurelike activity Am J Emerg Med. 9:1991;321-324.
10. Einspuch B.C., Clark S.M. Near fatality results from health food store sleeping potion. Tex Med. 88:1992;10.
11. Ferrara S.D., Tedeschi L., Frison G., Rossi A. Fatality due to gamma-hydroxybutyric acid (GHB) and heroin intoxication. J For Sci. 40:1995;501-504.
12. Fischer G., Diamant K., Schneider C., Pezawas L., Presslich O., Frey R., Kapitany T., Kasper S. Gamma-hydroxy butyric acid (GHB) for detoxification treatment of opiate dependent patients. Eur Neuropsychopharm. 5(suppl.):1995;10-31. P- P-.
13. Gallimberti L., Canton G., Gentile N., Ferri M., Cibin M., Ferrara S.D., Fadda F., Gessa G.L. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet. 2:1989;787-789.
14. Gallimberti L., Ferri M., Ferrara S.D., Fadda F., Gessa G.L. Gamma-hydroxybutyric acid in the treatment of alcohol dependence. a double blind study Alcohol Clin Exp Res. 16:1992;673-676.
15. Gallimberti L., Cibin M., Pagnin P., Sabbion R., Pani P.P., Pirastu R., Ferrara S.D., Gessa G.L. Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome. Neuropsychopharmacology. 9:1993;77-81.
16. Gallimberti L., Schifano F., Forza G., Miconi L., Ferrara S.D. Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawal. Eur Arch Psychiatry Clin Neurosci. 244:1994;113-114.
17. Galloway G.P., Frederick S.L., Seymour R., Contini S.E., Smith D.E. Abuse and therapeutic potential of gamma-hydrdoxybutyric acid. Alcohol. 20:2000;253-269.
18. Gerra G., Fertonani-Affini G., Caccavari R., Zaimovic A., Tagliavini P., Riva M., Delsignore R. Gamma-hydroxy-butyric acid in the treatment of heroin addiction. Clin Neuropharmacol. 2-4:1994;357-360.
19. Gessa G.L., Agabio R., Carai M.A.M., Lobina C., Pani M., Reali R., Colombo G. Mechanism of the antialcohol effect of gamma-hydroxybutyric acid. Alcohol. 20:2000;271-276.
20. Gold M.S., Redmond D.E. Jr., Kleber H.D. Clonidine blocks acute opiate-withdrawal symptoms. Lancet. 2:1978;599-601.
21. James C. Another case of gamma hydroxybutyrate (GHB) overdose. J Emerg Nurs. 22:1996;97.
22. Kleinschmidt S., Mertzlufft F. Gamma-Hydroxu-Buttersäure - Hat sie einen Stellenwert in Anästhesie un Intensivmedizin? Anästhesiol. Intensivmed Norfallmed Schmerzther. 30:1995;393-402.
23. Laborit H. Sodium 4-hydroxybutyrate. Int J Neuropharmacol. 3:1964;433-452.
24. Laborit H., Buchard F., Laborit G., Kind A., Weber B. Emploi du 4-hydroxybutyrate de Na en anésthesie et en réanimation. Agressologie. 1:1960;549-560. a.
25. Laborit H., Jouany J.M., Gerard J., Fabiani F. Sur un substrat metabolique a action centrale inhibitrice. le 4-hydroxybutyrate de Na Presse Med. 68:1960;1867-1869. b.
26. Laborit H., Weber B. Essai d'interprétation du mode d'action métabolique de certains agents neurotropes III. le gamma hydroxybutirate Rev Agressol. 6:1965;169-173.
27. Langlois M., Lacrotte J., Ferrier J. Action du gamma-hydroxybutyrate de sodium sur les syndromes névrotiques et psycho-pathiques avec agitation psycho-motrice. Rev Agressol. 1:1960;431-433.
28. Levy M.I., Davis B.D., Mohs R.C., Trigos G.C., Mathe A.A., Davis K.L. Gamma-hydroxybutirate in the treament of schizophrenia. Psychiatr Res. 9:1983;1-8.
29. Luby S., Jones J., Zalewski A. GHB use in South Carolina. Am J Publ Health. 82:1992;128.
30. Mamelak M. Neurodegeneration, sleep, and cerebral energy metabolism. a testable hypothesis J Geriatr Psychiatry Neurol. 10:1977;29-32.
31. Moncini M., Masini E., Gambassi F., Mannaioni P.F. Gamma-hydroxybutyrate and alcohol-related syndromes. Alcohol. 20:2000;285-291.
32. Palatini P., Tedeschi L., Frison G., Padini R., Zordan R., Orlando R., Gallimberti L., Gessa G.L., Ferrara S.D. Dose dependent absorption and elimination of gamma-hydroxybutyric acid in health volunteers. Eur J Clin Pharmacol. 45:1993;353-356.
33. Rinaldi F., Puca F.M., Mastrosimone F., Memoli G. Sull'impiego del gamma-idrossibutirrato di sodio in terapia psichiatrica. Acta Neurol. 22:1967;21-41.
34. Rosen M.I., Pearsall H.R., Woods S.W., Kosten T.R. The effect of gamma-hydroxybutyric acid on naloxone-precipitated opiate withdrawal. Neuropsychopharmacology. 14:1996;187-193.
35. Rosenthal N.R., Perkel C., Singh P., Anand O., Miner C.R. A pilot open randomized trial of valproate and phenobarbital in the treatment of acute alcohol withdrawal. Am J Addict. 7:1998;189-197.
36. Ross T.M. Gamma-hydroxybutyrate overdose. two cases illustrate the unique aspects of this dangerous recreational drug J Emerg Nurs. 21:1995;374-376.
37. Sanguineti V., Angelo A., Frank M. Ghb. a home brew Am J Drug Alcohol Abuse. 23:1997;637-642.
38. Schuls S.C., Von Kommen D.P., Buchsbaum M.S., Roth R.H., Alexander P., Bumrey W.E. Gamma-hydroxybutyric acid treatment of schizophrenia. a pilot study Pharmacopsychiatria. 14:1981;129-134.
39. Snead O.C. Gamma-hydroxybutyrate. Life Sci. 20:1977;1935-1944.
40. Snead O.C. Gamma-hydroxybutyrate in the monkey (iii). effect of intravenous anticonvulsant drugs Neurology. 28:1978;1173-1178.
41. Snead O.C. The ontogeny of GABAergic enhancement of gamma-hydroxybutyrate model of generalized absence seizures. Epilepsia. 31:1990;363-368.
42. Snead O.C. Pharmacological models of generalized absence seizure in rodents. J Neural Transm. 35(suppl.):1992;7-19.
43. Snead O.C., Bearden L.J. Naloxone overcomes the dopaminergic, EEG, and behavioral effects of gamma-hydroxybutyrate. Neurology. 30:1980;832-838.
44. Snead O.C., Liu C.C. GABA receptor function in the gamma-hydroxybutyrate model of generalized absence seizures. Neuropharmacology. 32:1993;401-409.
45. Snead O.C., Bearden L.J., Pegram P. Effect of acute and chronic anticonvulsant administration on endogenous gamma-hydroxybutyrate in rat brain. Neuropharmacology. 19:1980;47-52.
46. Stunkard A.J., Messick S. The three factor eating questionnaire to measure dietary restrain, dishinibition and hunger. J Psychosom Res. 28:1983;71-83.
47. Tanaka Z., Mukai A., Takayanagi Y., Muto A., Mikami Y., Miyakoshi T., Araya M., Ohdaira T., Aizawa H. Clinical application of 4-hydroxybutyrate sodium and 4-butyrolactone in neuropsychiatric patients. Folia Psychiatr Neurol Jpn. 20:1966;9-17.